We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kohl's
KSS
$2.28B
| $90.8M | 0.69% |
2,230,473
+39,881
| +2% | +$1.16M |
|
27
First Horizon
FHN
$12.4B
| $90.8M | 0.69% |
7,112,655
+3,569,845
| +101% | +$41.8M |
|
28
JPMorgan Chase
JPM
$950B
| $83.6M | 0.63% |
657,927
+47,391
| +8% | +$5.3M |
|
29
Martin Marietta Materials
MLM
$33.4B
| $83.5M | 0.63% |
294,102
+74,651
| +34% | +$19.9M |
|
|
CERN
30
DELISTED
Cerner Corp
CERN
| $82.8M | 0.63% |
1,054,641
-168,008
| -14% | -$12.4M |
|
31
Fidelity National Information Services
FIS
$22.9B
| $81.7M | 0.62% |
577,832
+224,461
| +64% | +$32M |
|
32
Alphabet (Google) Class C
GOOG
$4.59T
| $80.3M | 0.61% |
917,000
+61,440
| +7% | +$5.18M |
|
33
BioMarin Pharmaceuticals
BMRN
$11.7B
| $77.2M | 0.58% |
880,336
+4,800
| +0.5% | +$381K |
|
|
34
Arch Capital
ACGL
$33.9B
| $76M | 0.58% |
2,108,229
+2,107,878
| +600,535% | +$69.2M |
|
35
PayPal
PYPL
$50.1B
| $74.7M | 0.57% |
318,752
+43,446
| +16% | +$9M |
|
|
36
Alphabet (Google) Class A
GOOGL
$4.62T
| $73.6M | 0.56% |
843,800
+116,500
| +16% | +$9.8M |
|
|
CHL
37
DELISTED
China Mobile Limited
CHL
| $68.9M | 0.52% |
2,414,479
-191,479
| -7% | -$5.92M |
|
38
Home Depot
HD
$347B
| $66.3M | 0.5% |
249,447
+26,867
| +12% | +$7.39M |
|
39
Keysight
KEYS
$58.3B
| $66M | 0.5% |
499,938
+7,656
| +2% | +$882K |
|
40
iShares MSCI EAFE ETF
EFA
$79.3B
| $65.9M | 0.5% |
902,741
+39,726
| +5% | +$2.72M |
|
41
PepsiCo
PEP
$190B
| $62.8M | 0.48% |
423,780
+52,569
| +14% | +$7.47M |
|
|
ACC
42
DELISTED
American Campus Communities, Inc.
ACC
| $62.3M | 0.47% |
1,456,441
+81,433
| +6% | +$3.25M |
|
43
Johnson & Johnson
JNJ
$614B
| $59.9M | 0.45% |
380,397
+35,283
| +10% | +$5.21M |
|
44
Micron Technology
MU
$1.01T
| $58.3M | 0.44% |
775,288
+34,995
| +5% | +$2.11M |
|
45
Neurocrine Biosciences
NBIX
$16.9B
| $58.2M | 0.44% |
606,892
+273,732
| +82% | +$26.4M |
|
46
ResMed
RMD
$32.4B
| $58M | 0.44% |
273,059
-6,629
| -2% | -$1.32M |
|
47
iShares Core S&P 500 ETF
IVV
$900B
| $56.8M | 0.43% |
151,251
+20,073
| +15% | +$7.14M |
|
48
Ralph Lauren
RL
$22.5B
| $56M | 0.42% |
539,505
+539,278
| +237,567% | +$45.2M |
|
49
Cisco
CSCO
$480B
| $55.6M | 0.42% |
1,242,962
+84,190
| +7% | +$3.46M |
|
50
Intel
INTC
$509B
| $55.6M | 0.42% |
1,115,323
+56,212
| +5% | +$2.75M |
|
Similar funds
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.